Clinical trial
Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I)
NCT00662116
Study timeline
Study start (unknown)2008-03-01Date precision: month
Registry last updated2009-01-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diastolic Heart Failureunresolved
Interventions
alagebriumDRUG
placeboDRUG
Sponsors & collaborators
Synvista Therapeutics, Inclead sponsor
Mapped research locations
MiamiFlorida, United States1BirminghamAlabama, United States1CincinnatiOhio, United States1IndianapolisIndiana, United States1JacksonvilleFlorida, United States1Oklahoma CityOklahoma, United States1CharlestonSouth Carolina, United States1Winston-SalemNorth Carolina, United States1La JollaCalifornia, United States1MilwaukeeWisconsin, United States1LouisvilleKentucky, United States1AlbanyNew York, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00662116 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.